
It is important to survey the molecular targets which are involved in tumor angiogenesis for the development of antiangiogenic agents as one of the cancer therapy. This article is meant to review the recent molecular targets of tumor angiogenesis and the molecular mechanism of antiangiogenic agents in human clinical trials.
Indoles, Vascular Cell Adhesion Molecule-1, Angiogenesis Inhibitors, Antineoplastic Agents, Gefitinib, Plasminogen, Cadherins, Peptide Fragments, Oxindoles, ErbB Receptors, Mice, Antigens, CD, Neoplasms, Quinazolines, Animals, Humans, Pyrroles, Propionates, Angiostatins
Indoles, Vascular Cell Adhesion Molecule-1, Angiogenesis Inhibitors, Antineoplastic Agents, Gefitinib, Plasminogen, Cadherins, Peptide Fragments, Oxindoles, ErbB Receptors, Mice, Antigens, CD, Neoplasms, Quinazolines, Animals, Humans, Pyrroles, Propionates, Angiostatins
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
